James Grant, the plan medical director, was among the most direct in explaining the rationale, pointing to the combination of skyrocketing costs and poor adherence as the primary drivers
The Most Concerning Long-Term Risks of GLP-1 Drugs Below are the strongest areas of concern based on clinical observations, case reports, patient outcomes, and developing research
Jun 26, 2026 Articles, GLP- 1 Agonist Therapy Center, Obesity, Obesity, Physician oriented, Safety, Therapies 1,668 views As demand for GLP-1 receptor agonists continues to outpace supply, many patients have turned to compounded medications obtained through telehealth companies, medical spas, wellness clinics, and compounding pharmacies
Potential risks include mild side effects like nausea from NAD+ infusions, but overall profiles are favorable.[40] Who Benefits Most from Combination NAD+ and 5-Amino-1MQ Therapy
If youre looking for a weight loss specialist in Des Moines to help you transform your body, schedule a consultation at SOMA